ASX - Delayed Quote AUD
Radiopharm Theranostics Limited (RAD.AX)
0.0220
+0.0010
+(4.76%)
As of May 13 at 3:08:08 PM GMT+10. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| Alland (Leila) Director (Non-Executive) | Other | Sep 13, 2024 | 1,071,740 |
| Baker (Michael John) Director (Non-Executive) | Other | Dec 8, 2023 | 117,411 |
| Canevari (Riccardo) Chief Executive Officer | Other | Dec 16, 2024 | 21,179,986 |
| Hains (Phillip) Director (Non-Executive) | Other | Sep 13, 2024 | 15,956,632 |
| Hopper (Paul) Executive Chairman | Sale | Dec 5, 2024 | 147,721,428 |
| Larkin (Hester) Director (Non-Executive) | Other | Sep 13, 2024 | 644,247 |
| Turner (Ian) Director (Non-Executive) | Purchase | Feb 19, 2025 | 6,255,292 |
Related Tickers
7AY1.BE Actinium Pharmaceuticals Inc
1.3540
-3.42%
AGN.AX Argenica Therapeutics Limited
0.7450
-0.67%
CHM.AX Chimeric Therapeutics Limited
0.0050
+25.00%
TYP.AX TRYPTAMINE FPO [TYP]
0.0360
+2.86%
PAR.AX Paradigm Biopharmaceuticals Limited
0.3350
+8.06%
DXB.AX Dimerix Limited
0.5950
-2.46%
CU6.AX Clarity Pharmaceuticals Ltd
2.5600
+15.32%
TLX.AX Telix Pharmaceuticals Limited
25.36
+3.64%
YMAB Y-mAbs Therapeutics, Inc.
4.1600
+2.21%
STOK Stoke Therapeutics, Inc.
8.93
-7.56%